Department of Research, Nazarbayev University School of Medicine, Astana, Kazakhstan.
Department of Research, Council for Nutritional and Environmental Medicine, Mo i Rana, Norway.
Curr Med Chem. 2024;31(27):4233-4248. doi: 10.2174/0109298673263003231228060800.
Iron deficiency and iron-related disorders are common health issues worldwide, affecting a significant proportion of the population. Diagnosis and management of these disorders rely heavily on using various iron-related biomarkers that can provide valuable clinical information.
This review article provides an overview of the most commonly used iron-related biomarkers, including serum ferritin, transferrin saturation, soluble transferrin receptor, zinc protoporphyrin, and free erythrocyte protoporphyrin. Other emerging biomarkers, such as hepcidin and retinol-binding protein 4, are also discussed.
Iron plays a vital role in various physiological processes, including oxygen transport, energy metabolism, and DNA synthesis. The article highlights the advantages and limitations of iron biomarkers and their clinical applications in diagnosing and managing iron deficiency and iron-related anemia.
Using iron-related biomarkers in screening and monitoring programs can improve patient outcomes and reduce healthcare costs.
缺铁和与铁相关的疾病是全球常见的健康问题,影响着相当大比例的人群。这些疾病的诊断和管理主要依赖于使用各种与铁相关的生物标志物,这些标志物可以提供有价值的临床信息。
本文综述了最常用的与铁相关的生物标志物,包括血清铁蛋白、转铁蛋白饱和度、可溶性转铁蛋白受体、锌原卟啉和游离红细胞原卟啉。还讨论了其他新兴的生物标志物,如铁调素和视黄醇结合蛋白 4。
铁在多种生理过程中发挥着重要作用,包括氧气运输、能量代谢和 DNA 合成。本文强调了铁生物标志物的优缺点及其在诊断和管理缺铁和与铁相关的贫血中的临床应用。
在筛查和监测计划中使用与铁相关的生物标志物可以改善患者的预后并降低医疗保健成本。